Table 2.
Characteristics of Patients With Other Antiosteoporotic Therapies and Without Corticosteroids Treated and Untreated With N‐BPs (1:1 Matched Cohorts)
| Patients with other antiosteoporotic therapies and without corticosteroids | ||
|---|---|---|
| Characteristic | Other antiosteoporosis | Bisphosphonates |
| n | 6065 | 6065 |
| Age (years), mean ± SD | 73.8 ± 10.7 | 73.8 ± 10.7 |
| Male, n (%) | 275 (4.5) | 275 (4.5) |
| Respiratory drugs, n (%) | 1019 (16.8) | 1019 (16.8) |
| Respiratory hospitalization, n (%) | 411 (6.8) | 411 (6.8) |
| Neoplasms, n (%) | 1000 (16.5) | 1000 (16.5) |
| CV hospitalization, n (%) | 1136 (18.7) | 1136 (18.7) |
| Antihypertensives, n (%) | 3827 (63.1) | 3827 (63.1) |
| Statins, n (%) | 2033 (33.5) | 2033 (33.5) |
| Antidiabetics, n (%) | 508 (8.4) | 508 (8.4) |
| Antidepressants, n (%) | 1152 (19.0) | 1152 (19.0) |
CV = cardiovascular.